ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,088Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 3647

$1.14M Total Retail Price of All Prescriptions

Rank: 161 out of 3647

1,289 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 1,289 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 1,289 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 22,545 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,372 1,106 1 1
LISINOPRIL 1,246 991 2 4
OMEPRAZOLE 1,209 901 3 3
GABAPENTIN 935 630 4 17
LEVOTHYROXINE SODIUM 760 643 5 5
METFORMIN HCL 754 576 6 6
ALPRAZOLAM 706 417 7 31
HYDROCODONE-ACETAMINOPHEN 662 389 S3 8 12
AMLODIPINE BESYLATE 627 572 9 2
HYDROCHLOROTHIAZIDE 624 554 10 9
PANTOPRAZOLE SODIUM 623 457 11 38
CITALOPRAM HBR 587 465 12 25
LOSARTAN POTASSIUM 459 368 13 11
ZOLPIDEM TARTRATE 453 335 14 14
TRAMADOL HCL 442 297 15 22
FUROSEMIDE 437 347 16 8
OXYCODONE HCL 424 222 S2 17 75
METOPROLOL TARTRATE 417 340 18 7
WARFARIN SODIUM 405 379 19 15
ATENOLOL 403 330 20 10
CARVEDILOL 397 330 21 20
LOVASTATIN 326 275 22 21
RANITIDINE HCL 326 241 22 29
FLUTICASONE PROPIONATE 323 203 24 32
PROAIR HFA 316 200 25 62
PREDNISONE 309 266 26 43
CRESTOR 286 216 27 19
TIZANIDINE HCL 275 132 28 126
ALENDRONATE SODIUM 261 218 29 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 248 198 30 36
GLIPIZIDE 245 212 31 41
TEMAZEPAM 244 190 32 47
PRAVASTATIN SODIUM 216 177 33 16
NORTRIPTYLINE HCL 207 101 34 273
MELOXICAM 204 164 35 33
VIAGRA 193 129 36 69
SYMBICORT 188 159 37 153
CLOPIDOGREL 187 137 38 26
METHOTREXATE 182 120 39 224
ADVAIR DISKUS 182 133 39 52
SERTRALINE HCL 177 113 41 27
ATORVASTATIN CALCIUM 170 131 42 13
DOXYCYCLINE HYCLATE 167 133 43 145
POTASSIUM CHLORIDE 163 129 44 24
DIGOXIN 162 127 45 51
TAMSULOSIN HCL 159 119 46 28
DONEPEZIL HCL 156 153 47 30
METOCLOPRAMIDE HCL 151 119 48 135
METHYLPREDNISOLONE 150 112 49 78
LORAZEPAM 149 124 50 73
ENALAPRIL MALEATE 146 120 51 35
PLAVIX 140 104 52 39
CIPROFLOXACIN HCL 140 106 52 53
OXYBUTYNIN CHLORIDE 139 115 54 107
CARBIDOPA-LEVODOPA 137 121 55 127
TRAZODONE HCL 136 59 56 64
INSULIN SYRINGE 135 81 57 76
LOSARTAN-HYDROCHLOROTHIAZIDE 135 123 57 48
DOXAZOSIN MESYLATE 129 126 59 57
ISOSORBIDE MONONITRATE ER 127 95 60 56
POLYETHYLENE GLYCOL 3350 125 99 61 143
GEMFIBROZIL 124 94 62 82
FENOFIBRATE 120 79 63 50
LEVOFLOXACIN 112 86 64 87
GLYBURIDE 110 97 R 65 54
GLYBURIDE-METFORMIN HCL 109 92 R 66 94
AZITHROMYCIN 107 84 67 34
NAMENDA 107 103 67 49
HYDROXYCHLOROQUINE SULFATE 105 64 69 274
VENTOLIN HFA 102 49 70 88
GLIMEPIRIDE 101 80 71 45
KLOR-CON 10 93 87 72 106
CLONIDINE HCL 92 85 73 46
ESTRADIOL 90 47 R 74 236
NOVOLIN 70-30 89 41 75 130
FLUOXETINE HCL 89 53 75 68
ESCITALOPRAM OXALATE 89 83 75 65
ZAFIRLUKAST 88 71 78 366
DILTIAZEM ER 86 75 79 167
BUMETANIDE 85 75 80 134
ALLOPURINOL 82 66 81 37
AMITRIPTYLINE HCL 81 26 R 82 105
METOPROLOL SUCCINATE 81 62 82 18
SYNTHROID 81 76 82 42
SPIRONOLACTONE 79 63 85 77
MECLIZINE HCL 79 67 85 85
LAMOTRIGINE 78 47 87 266
HYDROMORPHONE HCL 75 51 S2 88 235
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 55 88 110
PAROXETINE HCL 73 25 90 60
CLOTRIMAZOLE-BETAMETHASONE 69 56 91 84
SPIRIVA 69 51 91 93
LANTUS 68 38 93 59
AMOXICILLIN 68 48 93 133
VERAPAMIL ER 68 52 93 99
DICLOFENAC SODIUM 67 43 96 86
CYMBALTA 67 34 96 79
CELEBREX 66 42 98 111
METHADONE HCL 65 20 S2 99 174
FINASTERIDE 65 64 99 66
TERAZOSIN HCL 64 59 101 103
AGGRENOX 64 64 101 267
LEVOXYL 64 59 101 125
PROPRANOLOL HCL 63 52 104 156
HYDRALAZINE HCL 62 56 105 81
METRONIDAZOLE 62 47 105 247
DILTIAZEM HCL 60 48 107 253
FLUCONAZOLE 59 40 108 226
MIRTAZAPINE 58 37 109 63
SUCRALFATE 57 48 110 219
IBUPROFEN 57 27 110 55
TRICOR 56 14 112 144
BUSPIRONE HCL 55 20 113 162
FAMOTIDINE 54 45 114 61
NOVOLIN R 53 37 115 139
LEXAPRO 52 51 116 177
BENAZEPRIL HCL 51 51 117 71
ONDANSETRON HCL 51 36 117 383
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.